Search research articles
Contact Us
Filters
Showing results (1-10 of 40) with videos related to
Page
of 4
Sort By:
Current Opinion in Drug Discovery & Development
|
February 20, 2008
Delivering silence: advancements in developing siRNA therapeutics
Tatiana I Novobrantseva, Akin Akinc, Anna Borodovsky, et al.
Thrombosis Research
|
September 8, 2020
Knockdown of liver-derived factor XII by GalNAc-siRNA ALN-F12 prevents thrombosis in mice without impacting hemostatic function
Jingxuan Liu, Brian C Cooley, Akin Akinc, et al.
Journal of Neuroscience Methods
|
March 5, 2022
A bioassay for neuromuscular junction-restricted complement activation by myasthenia gravis acetylcholine receptor antibodies
Jaap J Plomp, Maartje G M Huijbers, Jan J G M Verschuuren, et al.
Molecular Immunology
|
November 5, 2002
The ubiquitin-proteasome pathway in thymocyte apoptosis: caspase-dependent processing of the deubiquitinating enzyme USP7 (HAUSP)
Yulia Vugmeyster, Anna Borodovsky, Madelon M Maurice, et al.
Journal of Proteome Research
|
April 29, 2004
Chemistry-based functional proteomics: mechanism-based activity-profiling tools for ubiquitin and ubiquitin-like specific proteases
Joris Hemelaar, Paul J Galardy, Anna Borodovsky, et al.
Current Protocols in Protein Science
|
April 23, 2008
Applications for chemical probes of proteolytic activity
Matthew Bogyo, Amos Baruch, Douglas A Jeffery, et al.
Chemistry & Biology
|
October 29, 2002
Chemistry-based functional proteomics reveals novel members of the deubiquitinating enzyme family
Anna Borodovsky, Huib Ovaa, Nagamalleswari Kolli, et al.
Clinical Pharmacokinetics
|
October 13, 2020
Pharmacokinetic and Pharmacodynamic Properties of Cemdisiran, an RNAi Therapeutic Targeting Complement Component 5, in Healthy Subjects and Patients with Paroxysmal Nocturnal Hemoglobinuria
Prajakta Badri, Xuemin Jiang, Anna Borodovsky, et al.
The Journal of Biological Chemistry
|
December 19, 2002
Pathways accessory to proteasomal proteolysis are less efficient in major histocompatibility complex class I antigen production
Benedikt Kessler, Xu Hong, Jelena Petrovic, et al.
Clinical Pharmacokinetics
|
May 17, 2022
Correction to: Pharmacokinetic and Pharmacodynamic Properties of Cemdisiran, an RNAi Therapeutic Targeting Complement Component 5, in Healthy Subjects and Patients with Paroxysmal Nocturnal Hemoglobinuria
Prajakta Badri, Xuemin Jiang, Anna Borodovsky, et al.
Page
of 4
Search research articles
Search
Showing results (1-10 of 40) with videos related to
Sort By:
Page
of 4
Current Opinion in Drug Discovery & Development
|
February 20, 2008
Delivering silence: advancements in developing siRNA therapeutics
Tatiana I Novobrantseva, Akin Akinc, Anna Borodovsky, et al.
Thrombosis Research
|
September 8, 2020
Knockdown of liver-derived factor XII by GalNAc-siRNA ALN-F12 prevents thrombosis in mice without impacting hemostatic function
Jingxuan Liu, Brian C Cooley, Akin Akinc, et al.
Journal of Neuroscience Methods
|
March 5, 2022
A bioassay for neuromuscular junction-restricted complement activation by myasthenia gravis acetylcholine receptor antibodies
Jaap J Plomp, Maartje G M Huijbers, Jan J G M Verschuuren, et al.
Molecular Immunology
|
November 5, 2002
The ubiquitin-proteasome pathway in thymocyte apoptosis: caspase-dependent processing of the deubiquitinating enzyme USP7 (HAUSP)
Yulia Vugmeyster, Anna Borodovsky, Madelon M Maurice, et al.
Journal of Proteome Research
|
April 29, 2004
Chemistry-based functional proteomics: mechanism-based activity-profiling tools for ubiquitin and ubiquitin-like specific proteases
Joris Hemelaar, Paul J Galardy, Anna Borodovsky, et al.
Current Protocols in Protein Science
|
April 23, 2008
Applications for chemical probes of proteolytic activity
Matthew Bogyo, Amos Baruch, Douglas A Jeffery, et al.
Chemistry & Biology
|
October 29, 2002
Chemistry-based functional proteomics reveals novel members of the deubiquitinating enzyme family
Anna Borodovsky, Huib Ovaa, Nagamalleswari Kolli, et al.
Clinical Pharmacokinetics
|
October 13, 2020
Pharmacokinetic and Pharmacodynamic Properties of Cemdisiran, an RNAi Therapeutic Targeting Complement Component 5, in Healthy Subjects and Patients with Paroxysmal Nocturnal Hemoglobinuria
Prajakta Badri, Xuemin Jiang, Anna Borodovsky, et al.
The Journal of Biological Chemistry
|
December 19, 2002
Pathways accessory to proteasomal proteolysis are less efficient in major histocompatibility complex class I antigen production
Benedikt Kessler, Xu Hong, Jelena Petrovic, et al.
Clinical Pharmacokinetics
|
May 17, 2022
Correction to: Pharmacokinetic and Pharmacodynamic Properties of Cemdisiran, an RNAi Therapeutic Targeting Complement Component 5, in Healthy Subjects and Patients with Paroxysmal Nocturnal Hemoglobinuria
Prajakta Badri, Xuemin Jiang, Anna Borodovsky, et al.
Page
of 4